(TA)MUC1 as a potential new target for breast cancer therapy

被引：0
|
作者：
Heimes, A. S. [1 ]
Fries, P. [1 ]
Stergiou, N. [2 ]
Attariya, R. [3 ]
Hasenburg, A. [1 ]
Schmidt, M. [1 ]
Schmitt, E. [3 ]
Brenner, W. [1 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Univ Med, Klin & Poliklin Geburtshilfe & Frauengesundheit, Mainz, Germany
[2] Vrije Univ Amsterdam, UMC, Radiol & Nucl Med, Radionuclide Ctr, Amsterdam, Netherlands
[3] Johannes Gutenberg Univ Mainz, Univ Med, Inst Immunol, Mainz, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2020年 / 80卷 / 10期
关键词：
D O I：
10.1055/s-0040-1718204
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P376
引用
收藏
页码：E213 / E213
页数：1
相关论文
共 50 条
  • [21] Mucin-1 (MUC1) as a promising molecular target in anticancer therapy
    Gornowicz, Agnieszka
    Bielawska, Anna
    Poplawska, Bozena
    Bielawski, Krzysztof
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2019, 73 : 53 - 64
  • [22] Functional studies of the MUC1 oncoprotein in human breast cancer
    Hattrup, Christine L.
    Gendler, Sandra J.
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [23] IS EPISIALIN MUC1 INVOLVED IN BREAST-CANCER PROGRESSION
    HILKENS, J
    VOS, HL
    WESSELING, J
    BOER, M
    STORM, J
    VANDERVALK, S
    CALAFAT, J
    PATRIARCA, C
    [J]. CANCER LETTERS, 1995, 90 (01) : 27 - 33
  • [24] Analysis of the promoter of the MUC1 gene overexpressed in breast cancer
    Zaretsky, JZ
    Sarid, R
    Aylon, Y
    Mittelman, LA
    Wreschner, DH
    Keydar, I
    [J]. FEBS LETTERS, 1999, 461 (03) : 189 - 195
  • [25] MUC1: A metabolic regulator in triple negative breast cancer
    Goode, Gennifer D.
    Chaika, Nina
    Purohit, Vinee
    Gunda, Venugopal
    Singh, Pankaj
    [J]. CANCER RESEARCH, 2016, 76
  • [26] Inhibiting breast cancer progression with a MUC1 mimetic peptide
    Bitler, Benjamin G.
    Menzl, Ina
    Huerta, Carmen
    Schroeder, Joyce A.
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (07) : 874 - 874
  • [27] MUC1 and the Immunobiology of Cancer
    Joyce Taylor-Papadimitriou
    Joy M. Burchell
    Timothy Plunkett
    Rosalind Graham
    Isabel Correa
    David Miles
    Michael Smith
    [J]. Journal of Mammary Gland Biology and Neoplasia, 2002, 7 : 209 - 221
  • [28] MUC1 and the immunobiology of cancer
    Taylor-Papadimitriou, J
    Burchell, JM
    Plunkett, T
    Graham, R
    Correa, I
    Miles, D
    Smith, M
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2002, 7 (02) : 209 - 221
  • [29] MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells
    Hanafi-Bojd, Mohammad Yahya
    Kalat, Seyedeh Alia Moosavian
    Taghdisi, Seyed Mohammad
    Ansari, Legha
    Abnous, Khalil
    Malaekeh-Nikouei, Bizhan
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (01) : 13 - 18
  • [30] Inhibiting MUC1 a/b chain interaction mediates cytotoxicity of cells expressing MUC1: The MUC1 dyad oncoprotein as a functional target
    Karmely, M.
    Rubinstein, D. B.
    Pichinuk, E.
    Ziv, R.
    Benhar, I.
    Feng, N.
    Wreschner, D. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345